160 related articles for article (PubMed ID: 33326644)
21. Commentary on 'Liver resection versus transarterial chemoembolisation for the treatment of intermediate hepatocellular carcinoma: a systematic review and meta-analysis'.
Lu X; Liao Y; Liu Y; Shi F
Int J Surg; 2024 Jan; 110(1):589-590. PubMed ID: 37800534
[No Abstract] [Full Text] [Related]
22. Non-surgical treatment of hepatocellular carcinoma.
Johnson PJ
HPB (Oxford); 2005; 7(1):50-5. PubMed ID: 18333161
[TBL] [Abstract][Full Text] [Related]
23. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
Llovet JM; De Baere T; Kulik L; Haber PK; Greten TF; Meyer T; Lencioni R
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):293-313. PubMed ID: 33510460
[TBL] [Abstract][Full Text] [Related]
24. Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma.
Pinato DJ; Fessas P; Sapisochin G; Marron TU
Hepatology; 2021 Jul; 74(1):483-490. PubMed ID: 33369758
[No Abstract] [Full Text] [Related]
25. Immunotherapy and chimeric antigen receptor T-cell therapy in hepatocellular carcinoma.
Uson Junior PLS; Liu AJ; Sonbol MB; Borad MJ; Bekaii-Saab TS
Chin Clin Oncol; 2021 Feb; 10(1):11. PubMed ID: 33541088
[TBL] [Abstract][Full Text] [Related]
26. Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma.
Kalasekar SM; Garrido-Laguna I; Evason KJ
Hepatology; 2021 Jun; 73(6):2591-2593. PubMed ID: 33434363
[No Abstract] [Full Text] [Related]
27. Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials.
Facciorusso A; Abd El Aziz MA; Tartaglia N; Ramai D; Mohan BP; Cotsoglou C; Pusceddu S; Giacomelli L; Ambrosi A; Sacco R
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33339274
[TBL] [Abstract][Full Text] [Related]
28. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.
Liang L; Li C; Diao YK; Jia HD; Xing H; Pawlik TM; Lau WY; Shen F; Huang DS; Zhang CW; Yang T
Therap Adv Gastroenterol; 2020; 13():1756284820977693. PubMed ID: 33329759
[TBL] [Abstract][Full Text] [Related]
29. Combined PD-1/VEGFR Blockade: A New Era of Treatment for Hepatocellular Cancer.
Pinato DJ; Fessas P; Cortellini A; Rimassa L
Clin Cancer Res; 2021 Feb; 27(4):908-910. PubMed ID: 33328343
[TBL] [Abstract][Full Text] [Related]
30. Case Report: Transarterial Chemoembolization in Combination With Tislelizumab Downstages Unresectable Hepatocellular Carcinoma Followed by Radical Salvage Resection.
Chao J; Zhu Q; Chen D; An X; Liu A; Zhou F; Yuan L; Wang Z; Sun H
Front Oncol; 2021; 11():667555. PubMed ID: 33869071
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response.
Liou H; Mody K; Boyle AW; Keaveny AP; Croome KP; Burns JM; Harnois DM; Patel TC; Toskich B
Hepatology; 2021 Jul; 74(1):525-527. PubMed ID: 33615518
[No Abstract] [Full Text] [Related]
32. Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma.
Guo J; Wang S; Han Y; Jia Z; Wang R
Oncol Lett; 2021 Jul; 22(1):554. PubMed ID: 34084221
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma.
Llovet JM; Kelley RK; Villanueva A; Singal AG; Pikarsky E; Roayaie S; Lencioni R; Koike K; Zucman-Rossi J; Finn RS
Nat Rev Dis Primers; 2021 Jan; 7(1):6. PubMed ID: 33479224
[TBL] [Abstract][Full Text] [Related]
34. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
Pinato DJ; Murray SM; Forner A; Kaneko T; Fessas P; Toniutto P; MÃnguez B; Cacciato V; Avellini C; Diaz A; Boyton RJ; Altmann DM; Goldin RD; Akarca AU; Marafioti T; Mauri FA; Casagrande E; Grillo F; Giannini E; Bhoori S; Mazzaferro V
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593621
[TBL] [Abstract][Full Text] [Related]
35. Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma.
Mei J; Li SH; Li QJ; Sun XQ; Lu LH; Lin WP; Zheng L; Chen MS; Shi M; Wei W; Guo RP
J Hepatocell Carcinoma; 2021; 8():167-176. PubMed ID: 33791252
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study.
Zheng L; Fang S; Wu F; Chen W; Chen M; Weng Q; Wu X; Song J; Zhao Z; Ji J
Front Mol Biosci; 2020; 7():609322. PubMed ID: 33521054
[No Abstract] [Full Text] [Related]
37. Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu HD; Li HL; Huang MS; Yang WZ; Yin GW; Zhong BY; Sun JH; Jin ZC; Chen JJ; Ge NJ; Ding WB; Li WH; Huang JH; Mu W; Gu SZ; Li JP; Zhao H; Wen SW; Lei YM; Song YS; Yuan CW; Wang WD; Huang M; Zhao W; Wu JB; Wang S; Zhu X; Han JJ; Ren WX; Lu ZM; Xing WG; Fan Y; Lin HL; Zhang ZS; Xu GH; Hu WH; Tu Q; Su HY; Zheng CS; Chen Y; Zhao XY; Fang ZT; Wang Q; Zhao JW; Xu AB; Xu J; Wu QH; Niu HZ; Wang J; Dai F; Feng DP; Li QD; Shi RS; Li JR; Yang G; Shi HB; Ji JS; Liu YE; Cai Z; Yang P; Zhao Y; Zhu XL; Lu LG; Teng GJ;
Signal Transduct Target Ther; 2023 Feb; 8(1):58. PubMed ID: 36750721
[TBL] [Abstract][Full Text] [Related]
38. Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real world.
Xie D; Sun Q; Wang X; Zhou J; Fan J; Ren Z; Gao Q
Ann Transl Med; 2021 Apr; 9(8):652. PubMed ID: 33987350
[TBL] [Abstract][Full Text] [Related]
39. Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib
Mei J; Tang YH; Wei W; Shi M; Zheng L; Li SH; Guo RP
Front Oncol; 2021; 11():618206. PubMed ID: 33718175
[TBL] [Abstract][Full Text] [Related]
40. Combination treatment for advanced hepatocellular carcinoma with portal vein tumour thrombus: A case report.
Wang J; Wang J; Wang J; Qian Z; Xu W; Hang X
J Int Med Res; 2021 Feb; 49(2):300060521994406. PubMed ID: 33596694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
